Abbott Laboratories vs Medtronic plc. — Stock Comparison
Abbott Laboratories (ABT) and Medtronic plc. (MDT) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Medtronic plc. scores ahead of Abbott Laboratories on Q·Score (7.4 vs 6.5 out of 10), led by Growth (7.9 vs 5.5) and Quality (6.7 vs 5.7). Abbott Laboratories scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for MDT (+6.0%) than for ABT (+3.0%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
78% of 27 covering analysts have a positive rating.
Consistently beats earnings estimates (4/4 quarters).
Analyst Consensus
Fundamentals
Frequently Asked Questions
ABT vs MDT: which stock scores better overall?
Based on Q·Score, Medtronic plc. (MDT) scores 7.4/10 versus Abbott Laboratories (ABT) at 6.5/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ABT or MDT?
Medtronic plc. (MDT) scores higher on Growth (7.9/10 vs 5.5/10). Abbott Laboratories reports revenue growth (13.0% YoY) while Medtronic plc. reports (9.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ABT or MDT more attractively valued?
Medtronic plc. (MDT) scores higher on Valuation (7.5/10 vs 6.8/10). ABT trades at 19.2× P/E versus MDT at 14.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ABT vs MDT?
There are 25 analysts covering ABT with a consensus price target of $120.20, and 25 analysts covering MDT with a consensus target of $98.44. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ABT or MDT?
Medtronic plc. (MDT) scores higher on Quality (6.7/10 vs 5.7/10). Net profit margin: ABT at 11.6%, MDT at 13.2%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ABT or MDT?
Medtronic plc. (MDT) scores higher on Financial Health (7.9/10 vs 7/10). Market beta: ABT at 0.58, MDT at 0.57. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ABT and MDT?
Abbott Laboratories (ABT) has a market capitalisation of $201.9B, while Medtronic plc. (MDT) has a market cap of $118.9B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ABT or MDT pay dividends?
ABT pays a dividend yield of 2.16%, while MDT pays a dividend yield of 3.09%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →